PeptiGrowth is a supplier of innovative raw materials for the expanding market of regenerative medicine and cell and gene therapy. We develop, manufacture and market Alternative Peptides that have the same function as growth factors in preclinical and GMP quality. Our Alternative Peptides is manufactured by chemical synthesis method that does not use animal serum or gene recombination technology in order to achieve high purity, no variation among production lots in terms of specification, and cost reducing. PeptiGrowth is a joint venture of Mitsubishi Corporation and PeptiDream Inc.
PeptiGrowth, Inc.
Currently, numerous growth factors are known, but in order to realize a completely Xeno-free culture medium, multiple growth factors must be replaced by chemically synthesized products. PeptiGrowth utilizes PeptiDream's proprietary technology (PDPS) to become world-first to comprehensively develop numerous Growth Factor Alternative Peptides. We will contribute to the expansion of regenerative medicine and cell therapy by providing chemically synthesized Growth Factor Alternative Peptides with uniform quality.
The Latest Insights & Innovations from
PeptiGrowth, Inc.
No items found.
Podcast
#ExpertAnswers: Kosuke Minamihata and Jes Kuruvilla on Synthetic Peptides for Regenerative Medicine
May 5, 2023
Learn more
No items found.